Altogether, these data suggest that the severity of COVID-19 may be associated with inflammasome activation in monocytes that results in large amounts of IL-1ß and generates an excessive inflammatory response, further characterized by high levels of IL-6 and TNF-α. The gene discussed is IL1B; the disease is COVID-19.